PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 186 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2014. The put-call ratio across all filers is 0.99 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $4,083,000 | +18.0% | 60,000 | +71.4% | 0.62% | +52.7% |
| Q4 2017 | $3,460,000 | +6.2% | 35,000 | +153.7% | 0.41% | +19.8% |
| Q1 2015 | $3,257,000 | -15.2% | 13,796 | -32.0% | 0.34% | -48.2% |
| Q4 2014 | $3,841,000 | -46.9% | 20,296 | -33.0% | 0.65% | -26.8% |
| Q3 2014 | $7,228,000 | +338.1% | 30,296 | +21.2% | 0.89% | +119.4% |
| Q2 2014 | $1,650,000 | – | 25,000 | – | 0.41% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 1,792,114 | $4,713,260 | 4.15% |
| Eversept Partners, LP | 1,681,149 | $4,421,422 | 0.37% |
| Camber Capital Management LP | 4,235,000 | $11,138 | 0.37% |
| Kynam Capital Management, LP | 473,975 | $1,246,554 | 0.20% |
| GLOBEFLEX CAPITAL L P | 538,559 | $1,416,410 | 0.17% |
| Affinity Asset Advisors, LLC | 202,349 | $532,178 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 279,629 | $735 | 0.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 363,666 | $956,442 | 0.06% |
| Patriot Financial Group Insurance Agency, LLC | 67,000 | $176,210 | 0.04% |
| ACADIAN ASSET MANAGEMENT LLC | 1,858,000 | $4,884 | 0.02% |